Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
about
Lifelong reduction of LDL-cholesterol related to a common variant in the LDL-receptor gene decreases the risk of coronary artery disease--a Mendelian Randomisation studyGenome-wide association of lipid-lowering response to statins in combined study populationsLow density lipoprotein cholesterol is inversely correlated with abdominal visceral fat area: a magnetic resonance imaging studyA comprehensive review on metabolic syndromeInvestigation of microencapsulated BSH active lactobacillus in the simulated human GI tractLDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL ManagementMetabolomics reveals amino acids contribute to variation in response to simvastatin treatmentThe preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factorsCholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian YorubaHeart Disease and Stroke Statistics--2013 Update: A Report From the American Heart AssociationArtichoke leaf extract for treating hypercholesterolaemiaEzetimibe for primary hypercholesterolemiaPreoperative statin therapy for patients undergoing cardiac surgeryCombined therapy with statins and fibrates for people with dyslipidaemiaScreening for peripheral arterial diseaseArtichoke leaf extract for treating hypercholesterolaemiaPreoperative statin therapy for patients undergoing cardiac surgeryColesevelam for type 2 diabetes mellitusPreoperative statin therapy for patients undergoing cardiac surgeryColesevelam for type 2 diabetes mellitusArtichoke leaf extract for treating hypercholesterolaemiaHypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritisCombined therapy with statins and fibrates for people with dyslipidaemiaEzetimibe for primary hypercholesterolemiaRelation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapymTOR inhibitors in advanced renal cell carcinomaClinical assessment incorporating a personal genomeColesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of actionResistant starch from high-amylose maize increases insulin sensitivity in overweight and obese menWhy patients visit their doctors: assessing the most prevalent conditions in a defined American populationOpening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular riskLipoprotein(a), hormone replacement therapy, and risk of future cardiovascular eventsJupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Are statins diabetogenic?Standards of medical care in diabetes--2012Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose responseWaist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional studyMedical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesThe benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsInfluence of patient race on physician prescribing decisions: a randomized on-line experiment
P2860
Q21090089-93E652E0-A3BF-4B31-B05F-DFADD12DDCD5Q21142620-5D4D5954-85DE-4D29-890D-9ED9BE1EBFFEQ21245697-91251F5E-E49F-4F74-928C-0FE433EC19F8Q21284500-1BF7F512-B030-4DFA-ADA0-D6B4AAB98FF4Q21343017-3F1EAFC7-E4FB-4B40-AF7F-0FEBD025322DQ21558651-52F84F48-DACE-4335-856A-BC63A7FDC422Q21561017-31572D88-9102-417C-9125-16AC65DC0120Q21563399-F18F00B0-F466-4F60-AAF7-BE0044E8857EQ22241658-479EF7A1-6E22-4E96-9075-A12B62BA5F76Q22306356-7F74B418-1163-44E8-B59B-8C229AD53114Q24185798-EF2BF5D7-79C0-44BE-B315-CC63B745B3CFQ24187681-C0BC1A03-FC35-406B-94DB-B5527CB3B09DQ24187896-6CC8C92B-5705-436F-AEAF-1762535E2206Q24195172-13AE8462-92E6-4E7A-BEFD-084669B1856AQ24197484-739ECB28-0630-4CA2-AD1A-6C1699AE1786Q24198879-C0BA6382-FA66-420B-A730-A823052039CEQ24200475-16458567-D1ED-413E-90BD-4F152198B2A0Q24202334-BCFDD565-E450-4D30-9B68-81E8A577C699Q24236372-2DB76EDA-AB6F-481C-BB35-AA0F8EB697D5Q24236703-C17B9351-2177-47D6-A913-BFFD30B45ABAQ24240435-EDF74E62-A623-4600-9EAA-EC57D6961037Q24242787-1A61DDD2-5AC6-4F4F-ABD3-11BD2D65F9D9Q24243737-92820D4A-5590-4F9E-98C6-67927EC97EE0Q24244704-FFE1051A-62AD-42F8-98B4-4B50DB9B1D9CQ24594496-035DBDB3-BD9A-45CC-A621-DE96C6B3E1C0Q24612127-086EA688-F495-43E8-B341-DECDF6BA292AQ24612653-D41B2A43-E200-479C-AB39-D2AFB70B3AACQ24613405-DBC67EC3-3D2C-42C7-8C07-6003432B2C43Q24617779-B7C76AFA-701E-4EFC-9062-7C1CC9461668Q24626604-FF1E6A16-921E-40A3-B480-7CBB79320DEAQ24626884-90A5901C-0BE9-4DC9-A4AA-F50A1664B191Q24629580-290626EB-D4ED-4280-B2A8-6BFC0C208C7CQ24630160-0F109BB5-3B60-4610-B52A-FF0E9A3E21EFQ24630205-BF6B4934-2294-4603-92BE-2104D24D8886Q24632533-E158AF9A-0286-4209-A5C9-344A2BEE6A5EQ24632568-B17163A0-A6C2-41F4-837A-16C65753B5E4Q24633407-63684B33-6A8D-477E-BAC4-DBAF05945C8BQ24642503-E250A108-F959-455B-956D-4602E4889564Q24646234-DA73D836-A5E5-434A-981E-A270DBBDF16BQ24646319-FE6F5DDA-A8C2-4CFE-B83D-6F99C00F83AC
P2860
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
description
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Juli 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 13 July 2004)
@en
wetenschappelijk artikel (gepubliceerd op 2004/07/13)
@nl
наукова стаття, опублікована в липні 2004
@uk
مقالة علمية (نشرت في 13-7-2004)
@ar
name
Implications of recent clinica ...... Treatment Panel III guidelines
@ast
Implications of recent clinica ...... Treatment Panel III guidelines
@en
type
label
Implications of recent clinica ...... Treatment Panel III guidelines
@ast
Implications of recent clinica ...... Treatment Panel III guidelines
@en
prefLabel
Implications of recent clinica ...... Treatment Panel III guidelines
@ast
Implications of recent clinica ...... Treatment Panel III guidelines
@en
P2093
P3181
P1433
P1476
Implications of recent clinica ...... Treatment Panel III guidelines
@en
P2093
Brewer HB Jr
Cleeman JI
Hunninghake DB
Pasternak RC
Smith SC Jr
P304
P3181
P356
10.1161/01.CIR.0000133317.49796.0E
P407
P577
2004-07-13T00:00:00Z